Screening for gestational diabetes mellitus: A decision and cost-effectiveness analysis of four screening strategies

Diabetes Care

Volumn 28, Issue 6, 2005, Pages 1482-1484

  Nicholson, Wanda K ^a,b   Fleisher, Lee A ^c   Fox, Harold E ^a   Powe, Neil R ^a,b,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; FEMALE; GLUCOSE TOLERANCE TEST; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MEDICAL FEE; PREGNANCY DIABETES MELLITUS; PREVALENCE; QUALITY ADJUSTED LIFE YEAR; SCREENING TEST; VALIDATION PROCESS;

COST-BENEFIT ANALYSIS; DIABETES, GESTATIONAL; FEMALE; HUMANS; INFANT, NEWBORN; MASS SCREENING; MEDICARE; MODELS, BIOLOGICAL; PREGNANCY; UNITED STATES;

EID: 19944370143     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.6.1482     Document Type: Article

References (16)

1. Gabbe SG, Graves C: Management of diabetes mellitus complicating pregnancy. Obstet Gynecol 102:857-868, 2003
2. American Diabetes Association: Gestational diabetes mellitus (Position Statement). Diabetes Care 27 (Suppl. 1):S88-S90, 2004
3. Brody SC, Harris R, Lohr K: Screening for gestational diabetes: a summary of the evidence for the U.S. Preventive Services Task Force. Obstet Gynecol 101:380-392, 2003
4. Gabbe SG, Hill L, Schmidt L, Schulkin J: Management of diabetes by obstetrician-gynecologist. Obstet Gynecol 91:643-647, 1998
5. Russell L, Gold M, Siegel J, Daniels N, Winstein M: The role of cost-effectiveness analysis in health and medicine: panel on cost-effectiveness in health and medicine. JAMA 276:1172-1177, 1996
6. O'Sullivan JB, Mahan C: Criteria for the oral glucose tolerance test in pregnancy. Diabetes 13:278-285, 1964
7. World Health Organization: Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999 (WHO/NCD/NCS/99.2)
8. Poncet B, Touzet S, Rocher L, Berland M, Orgiazzi J, Colin C: Cost-effectiveness analysis of gestational diabetes mellitus screening in France. Eur J Obstet Gynecol Reprod Biol 103:122-129, 2002
9. Carpenter MW, Coustan D: Criteria for screening tests for gestational diabetes. Am J Obstet Gynecol 144:768-773, 1982
10. Health Care Financing Administration OACT, Office of National Statistics, New York, DRI/McGraw-Hill HCC, 2003
11. Maryland Health Care Commission Hospital Discharge Data, 1997-2001. Baltimore, MD, Department of Health and Mental Hygiene, 2003
12. Health Services Cost Review Commission Annual Cost Filings and Approved Rate Orders, 1997-2001. Baltimore, MD, Maryland Health Care Commission, 2003
13. Chung A, Macario A, El-Sayed Y, Riley E, Duncan G, Druzin M: Cost-effectiveness of a trial of labor after previous cesarean. Obstet Gynecol 97:932-941, 2000
14. Waitzman NJ, Romano P, Scheffler RM, Harris JA: Economic costs of birth defects and cerebral palsy-1992. MMWR 44:694-699, 1995
15. Bureau of the Census: Summary of population and wage earnings: Maryland, Washington, DC [article online], 2003. Available from http://www.bls.gov. Accessed 4 October 2004
16. Langer O, Anyaegbunam A, Brustman L, Divon M: Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy. Am J Obstet Gynecol 161:593-599, 1989